Investor Relations & Capital Introduction in Cambridge

Cambridge is one of the world's leading centres of science-led companies, built around the University of Cambridge and a dense cluster of life sciences, semiconductor and deep technology businesses. For research-derived founders, it offers exceptional expertise and specialist investors.

Why Cambridge Matters for Capital Raising

Cambridge attracted around $2 billion of venture investment in 2025, second only to London in the UK.

Arm, the chip designer whose architecture powers most of the world's smartphones, was founded in Cambridge in 1990, and the Cambridge Science Park, opened in 1970, was one of the first in Europe.

AstraZeneca's global headquarters and research centre, along with many biotechnology companies, make the city a leading European life sciences hub.

What Cambridge Investors Examine

Scientific quality, intellectual property and university arrangements are examined in detail.

Investors look for a clear path from technical readiness to a first paying customer.

Engagement and Access

GCN connects founders with Cambridge angel investors, specialist venture funds and family offices through conference programming and private sessions across the UK.

Sectors where we see consistent Cambridge interest include biotechnology and life sciences, semiconductors, artificial intelligence, quantum technology and climate technology.

Partner with Global Capital Network

Whether you are raising into Cambridge or allocating from it, our team can discuss how our investor relations infrastructure applies to your objectives.